GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » EV-to-EBIT

King International Investment (HKSE:00928) EV-to-EBIT : -5.68 (As of May. 11, 2024)


View and export this data going back to 2002. Start your Free Trial

What is King International Investment EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, King International Investment's Enterprise Value is HK$149.9 Mil. King International Investment's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-26.4 Mil. Therefore, King International Investment's EV-to-EBIT for today is -5.68.

The historical rank and industry rank for King International Investment's EV-to-EBIT or its related term are showing as below:

HKSE:00928' s EV-to-EBIT Range Over the Past 10 Years
Min: -208.96   Med: -3.51   Max: 379.48
Current: -5.68

During the past 13 years, the highest EV-to-EBIT of King International Investment was 379.48. The lowest was -208.96. And the median was -3.51.

HKSE:00928's EV-to-EBIT is ranked worse than
100% of 106 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.34 vs HKSE:00928: -5.68

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. King International Investment's Enterprise Value for the quarter that ended in Sep. 2023 was HK$115.8 Mil. King International Investment's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-26.4 Mil. King International Investment's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -22.81%.


King International Investment EV-to-EBIT Historical Data

The historical data trend for King International Investment's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

King International Investment EV-to-EBIT Chart

King International Investment Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.31 1.00 396.24 -3.26 -4.30

King International Investment Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.26 - -4.30 -

Competitive Comparison of King International Investment's EV-to-EBIT

For the Diagnostics & Research subindustry, King International Investment's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


King International Investment's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where King International Investment's EV-to-EBIT falls into.



King International Investment EV-to-EBIT Calculation

King International Investment's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=149.887/-26.408
=-5.68

King International Investment's current Enterprise Value is HK$149.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. King International Investment's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-26.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


King International Investment  (HKSE:00928) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

King International Investment's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-26.408/115.76222
=-22.81 %

King International Investment's Enterprise Value for the quarter that ended in Sep. 2023 was HK$115.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. King International Investment's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-26.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


King International Investment EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of King International Investment's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


King International Investment (HKSE:00928) Business Description

Traded in Other Exchanges
N/A
Address
18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG
King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

King International Investment (HKSE:00928) Headlines

No Headlines